0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
31.66%
Revenue growth above 1.5x 0376.HK's 9.51%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
24.43%
Gross profit growth above 1.5x 0376.HK's 9.51%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-226.33%
Negative EBIT growth while 0376.HK is at 78.69%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-226.33%
Negative operating income growth while 0376.HK is at 53.12%. Joel Greenblatt would press for urgent turnaround measures.
-3875.78%
Negative net income growth while 0376.HK stands at 111.73%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3833.33%
Negative EPS growth while 0376.HK is at 110.55%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-3833.33%
Negative diluted EPS growth while 0376.HK is at 110.55%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.06%
Share count expansion well above 0376.HK's 0.32%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
No Data
No Data available this quarter, please select a different quarter.
15.66%
Dividend growth of 15.66% while 0376.HK is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-11.97%
Negative OCF growth while 0376.HK is at 37.35%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-11.76%
Negative FCF growth while 0376.HK is at 37.32%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-14.04%
Negative 10Y revenue/share CAGR while 0376.HK stands at 1468.66%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
10.91%
Positive 5Y CAGR while 0376.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-11.76%
Negative 3Y CAGR while 0376.HK stands at 2371.80%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2249.52%
Negative 10Y OCF/share CAGR while 0376.HK stands at 341.58%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-932.93%
Negative 5Y OCF/share CAGR while 0376.HK is at 547.04%. Joel Greenblatt would question the firm’s operational model or cost structure.
6.00%
3Y OCF/share CAGR under 50% of 0376.HK's 1840.57%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
16.65%
Below 50% of 0376.HK's 126.12%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-645.85%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-245.29%
Negative 3Y CAGR while 0376.HK is 235.06%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
445.96%
10Y equity/share CAGR above 1.5x 0376.HK's 188.42%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
28.11%
5Y equity/share CAGR at 50-75% of 0376.HK's 38.87%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-0.65%
Negative 3Y equity/share growth while 0376.HK is at 69.53%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-91.76%
Cut dividends over 10 years while 0376.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
82.29%
AR growth of 82.29% while 0376.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
0.89%
Inventory growth of 0.89% while 0376.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
30.20%
Asset growth above 1.5x 0376.HK's 9.01%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-8.39%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
50.09%
Debt growth far above 0376.HK's 77.45%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
435.21%
R&D growth of 435.21% while 0376.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
11.64%
SG&A growth well above 0376.HK's 13.61%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.